Literature DB >> 29866385

Patient predictors of substance use disorder treatment initiation in primary care.

Allison J Ober1, Katherine E Watkins2, Colleen M McCullough3, Claude M Setodji4, Karen Osilla5, Sarah B Hunter6.   

Abstract

INTRODUCTION: Primary care clinics are opportune settings in which to deliver substance use disorder (SUD) treatment, but little is known about which patients initiate treatment in these settings.
METHODS: Using secondary data from a RCT that aimed to integrate SUD treatment into a federally qualified health center (FQHC) using an organizational readiness and collaborative care (CC) intervention, we examined patient-level predictors of initiation of evidence-based practices for opioid and/or alcohol use disorders (OAUDs): a brief behavioral treatment (BT) based on motivational interviewing and cognitive behavioral therapy and medication-assisted treatment (MAT) (extended-release injectable naltrexone (XR-NTX) for patients with an alcohol use disorder or opioid use disorder and buprenorphine/naloxone (BUP/NX) for patients with an opioid use disorder). Using the Andersen model of health care access, we tested bivariate and multivariate logistic regression models to assess associations between patient factors and initiation of BT and MAT.
RESULTS: Twenty-three percent of all participants (N = 392) received BT and 13% received MAT. In the multivariate model examining factors associated with initiation of BT, being of "other" or "multiple" races compared with being White (OR = 0.45, CI = 0.22, 0.92), being homeless (OR = 0.45, CI = 0.21, 0.97) and having been arrested within 90 days of baseline (OR = 0.21 CI = 0.63, 0.69) were associated with significantly lower odds of initiating BT. Greater self-stigma (OR = 1.60, CI = 1.06, 2.42), receiving MAT (OR = 5.52, CI = 2.34, 12.98), and having received the CC study intervention (OR = 12.95, CI = 5.91, 28.37) were associated with higher odds of initiating BT. In the multivariate model examining patient factors associated with initiating MAT, older age (OR = 1.07, CI = 1.03, 1.11), female gender (OR = 3.05, CI = 1.25, 7.46), having a diagnosis of heroin abuse or dependence (with or without alcohol abuse or dependence compared with have a diagnosis of alcohol dependence only (OR = 3.03, CI = 1.17, 7.86), and having received at least one session of BT (OR = 6.42, CI = 2.59, 15.94), were associated with higher odds of initiating MAT.
CONCLUSIONS: Individuals who initiate BT for OAUDs in a FQHC are less likely to be homeless and more likely to have greater self-stigma. Those who receive MAT are more likely to be of older age, female, and to have a diagnosis of heroin abuse or dependence, with or without concomitant alcohol abuse or dependence, rather than alcohol abuse or dependence alone. Receiving collaborative care (e.g., a warm handoff, and follow-up by a care coordinator) may be critical to initiating BT. Receiving at least one session of BT is associated with higher odds of receiving MAT, and receiving MAT is associated with higher odds of receiving BT. The Andersen model of health care access provides some insight into who initiates BT and MAT for OAUD treatment in FQHC-based primary care; further research is needed to explore system-level factors that may also influence treatment initiation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Community health center; FQHC; Federally qualified health center; MAT; Medication-assisted treatment; Primary care; Substance use disorder treatment predictors

Mesh:

Substances:

Year:  2018        PMID: 29866385      PMCID: PMC6336395          DOI: 10.1016/j.jsat.2018.04.004

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  58 in total

1.  Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance.

Authors:  Constance Weisner; Helen Matzger; Tammy Tam; Laura Schmidt
Journal:  J Stud Alcohol       Date:  2002-11

2.  Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert F Forman; Dace Svikis; Ivan D Montoya; Jack Blaine
Journal:  J Subst Abuse Treat       Date:  2004-07

Review 3.  Defining organizational capacity for public health services and systems research.

Authors:  Anne-Marie Meyer; Meredith Davis; Glen P Mays
Journal:  J Public Health Manag Pract       Date:  2012-11

4.  Towards greater understanding of addiction stigma: Intersectionality with race/ethnicity and gender.

Authors:  Magdalena Kulesza; Mauri Matsuda; Jason J Ramirez; Alexandra J Werntz; Bethany A Teachman; Kristen P Lindgren
Journal:  Drug Alcohol Depend       Date:  2016-10-21       Impact factor: 4.492

5.  Trends in alcohol- and drug-related emergency department and primary care visits: data from four U.S. national surveys (1995-2010).

Authors:  Cheryl J Cherpitel; Yu Ye
Journal:  J Stud Alcohol Drugs       Date:  2012-05       Impact factor: 2.582

6.  Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.

Authors:  Philip W Appel; Aletha A Ellison; Hadley K Jansky; Rivka Oldak
Journal:  Am J Drug Alcohol Abuse       Date:  2004       Impact factor: 3.829

7.  Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program.

Authors:  Carla A Green; Michael R Polen; Daniel M Dickinson; Frances L Lynch; Marjorie D Bennett
Journal:  J Subst Abuse Treat       Date:  2002-12

Review 8.  Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.

Authors:  John Mendelson; Keith Flower; Mark J Pletcher; Gantt P Galloway
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

9.  Assessing consequences of substance use: psychometric properties of the inventory of drug use consequences.

Authors:  Kimberly A Blanchard; Jon Morgenstern; Thomas J Morgan; Erich W Lobouvie; Donald A Bux
Journal:  Psychol Addict Behav       Date:  2003-12

Review 10.  Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence.

Authors:  Sofie Mauger; Ronald Fraser; Kathryn Gill
Journal:  Neuropsychiatr Dis Treat       Date:  2014-04-07       Impact factor: 2.570

View more
  12 in total

1.  Opioid and Substance Use Disorder and Receipt of Treatment Among Parents Living With Children in the United States, 2015-2017.

Authors:  Lisa Clemans-Cope; Victoria Lynch; Marni Epstein; Genevieve M Kenney
Journal:  Ann Fam Med       Date:  2019-05       Impact factor: 5.166

2.  Retention of Patients With Multiple Vulnerabilities in a Federally Qualified Health Center Buprenorphine Program: Pennsylvania, 2017-2018.

Authors:  Lara Carson Weinstein; Qais Iqbal; Amy Cunningham; Robin Debates; Greg Landistratis; Patrick Doggett; Alexis Silverio
Journal:  Am J Public Health       Date:  2020-02-20       Impact factor: 9.308

3.  Improving Medication Access within Integrated Treatment for Individuals with Co-Occurring Disorders in Substance Use Treatment Agencies.

Authors:  James H Ford; Arveen Kaur; Deepika Rao; Aaron Gilson; Daniel M Bolt; Helene Chokron Garneau; Lisa Saldana; Mark P McGovern
Journal:  Implement Res Pract       Date:  2021-09-17

4.  Nurse-led intervention to decrease drug use among LTBI positive homeless adults.

Authors:  Adeline Nyamathi; Donald Morisky; Sarah Akure Wall; Kartik Yadav; Sangshuk Shin; Elizabeth Hall; Alicia H Chang; Kathryn White; Nicholas Arce; Therese Parsa; Benissa E Salem
Journal:  Public Health Nurs       Date:  2022-01-10       Impact factor: 1.770

5.  Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.

Authors:  Denise M Boudreau; Gwen Lapham; Eric A Johnson; Jennifer F Bobb; Abigail G Matthews; Jennifer McCormack; David Liu; Cynthia I Campbell; Rebecca C Rossom; Ingrid A Binswanger; Bobbi Jo Yarborough; Julia H Arnsten; Chinazo O Cunningham; Joseph E Glass; Mark T Murphy; Mohammad Zare; Rulin C Hechter; Brian Ahmedani; Jordan M Braciszewski; Viviana E Horigian; José Szapocznik; Jeffrey H Samet; Andrew J Saxon; Robert P Schwartz; Katharine A Bradley
Journal:  J Subst Abuse Treat       Date:  2020-03

6.  Mental Health and Psychosocial Needs of Patients Being Treated for Opioid Use Disorder in a Primary Care Residency Clinic.

Authors:  Stephanie A Hooker; Michelle D Sherman; Mary Lonergan-Cullum; Adam Sattler; Bruce S Liese; Kathryn Justesen; Tanner Nissly; Robert Levy
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

7.  "I Felt I Was Reaching a Point with My Health": Understanding Reasons for Engagement and Acceptability of Treatment Services for Unhealthy Alcohol Use in Primary Care.

Authors:  Megan A O'Grady; Joseph Conigliaro; Svetlana Levak; Jeanne Morley; Sandeep Kapoor; Melanie Ritter; Christina Marini; Jon Morgenstern
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

8.  Examining trends in substance use disorder capacity and service delivery by Health Resources and Services Administration-funded health centers: A time series regression analysis.

Authors:  Nadereh Pourat; Brenna O'Masta; Xiao Chen; Connie Lu; Weihao Zhou; Marlon Daniel; Hank Hoang; Alek Sripipatana
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

9.  Development of a machine learning algorithm for early detection of opioid use disorder.

Authors:  Zvi Segal; Kira Radinsky; Guy Elad; Gal Marom; Moran Beladev; Maor Lewis; Bar Ehrenberg; Plia Gillis; Liat Korn; Gideon Koren
Journal:  Pharmacol Res Perspect       Date:  2020-12

Review 10.  Financial sustainability of payment models for office-based opioid treatment in outpatient clinics.

Authors:  Dominic Hodgkin; Constance Horgan; Gavin Bart
Journal:  Addict Sci Clin Pract       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.